Sexual Assault Author: Carolyn J. Sachs, MD, MPH
Editorial changes - 2009-11-04
Author information and module status
Prevention
Screening
Diagnosis
Consultation for Diagnosis
Hospitalization
Non-drug Therapy
Drug Therapy
Patient Education
Consultation for Management
Follow-up

Tables
Figures
References
Glossary
What's New
Patient Information
Additional Resources
Tools
Drug Therapy
  • Offer antibiotic treatment to prevent commonly identified bacterial STDs after assault involving oral-genital or genital-genital contact.
  • Counsel patients on the risk of HIV from sexual contact and offer HIV prophylaxis after high-risk sexual assault.
  • Offer hepatitis B prevention in cases involving the potential for blood or semen transfer.
  • Offer pregnancy prevention with hormonal postcoital contraception to female patients after penile-vaginal assault.
Drug Treatment After Sexual Assault (table)


Offer antibiotic treatment to prevent commonly identified bacterial STDs after assault involving oral-genital or genital-genital contact. B

  • Administer antibiotic medications to prevent sexually transmitted bacterial diseases including gonorrhea, chlamydia, and syphilis.
  • Give appropriate tetanus prophylaxis to patients sustaining lacerations and/or abrasions who lack adequate up-to-date immunization.
  • See table Drug Treatment After Sexual Assault.
Background | Back to top


Counsel patients on the risk of HIV from sexual contact and offer HIV prophylaxis after high-risk sexual assault. BC

  • Assess risk category, given the suspected perpetrator and sexual act.
  • Advise patients of their risk category.
  • Counsel patients and offer the option of taking anti-HIV medicines if available.
  • Give anti-HIV medications to victims assaulted by a person who is known to be HIV positive after an assault that carries a measurable risk according to the CDC recommendations released in 2005.
  • See module Human Immunodeficiency Virus Disease.
  • See table Drug Treatment After Sexual Assault.
Background | Back to top


Offer hepatitis B prevention in cases involving the potential for blood or semen transfer. C

  • Offer hepatitis B surface antibody testing with follow-up vaccination if the test result is negative; offer hepatitis B vaccination to unvaccinated patients or patients who are unsure of their vaccination status.
  • Administer HBIg to nonimmune patients after a high-risk exposure to a known hepatitis B-positive perpetrator.
  • See module Hepatitis B.
  • See table Drug Treatment After Sexual Assault.
Background | Back to top


Offer pregnancy prevention with hormonal postcoital contraception to female patients after penile-vaginal assault. AB

  • Administer pregnancy prevention with a single dose of levonorgestrel, 1.5 mg.
  • Offer postcoital contraception up to 5 days after assault in nonpregnant females of childbearing age who lack ongoing anatomic contraception (i.e., tubal ligation, absent uterus, or presence of an IUD).
  • See module Prevention of Unintended Pregnancy.
  • See table Drug Treatment After Sexual Assault.
Background | Back to top

FAQs
Carolyn J. Sachs, MD, MPH has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations.
Steven E. Weinberger, MD, FACP, Acting Editor, PIER, has stock holdings in Glaxosmithkline and Abbott.


The information included herein should never be used as a substitute for clinical judgment and does not represent an official position of ACP. Because all PIER modules are updated regularly, printed web pages or PDFs may rapidly become obsolete. Therefore, PIER users should compare the date of the last update on the website with any printout to ensure that the information being referred to is the most current available.
PIER is copyrighted (c) 2009 by the American College of Physicians,
190 N. Independence Mall West, Philadelphia, PA 19106-1572, USA.